CAC
CLBTW

Cowen and Company’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

Cowen and Company’s Portfolio CLBTW Stock Details CLBTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-53,497
Closed -$115K – 749
2024
Q1 		$115K Sell
53,497
-146,503
-73% -$290K ﹤0.01% 279
2023
Q4 		$314K Buy
200,000
+23,874
+14% +$28K 0.02% 195
2023
Q3 		$224K Buy
+176,126
New +$224K 0.02% 206

Other funds holding CLBTW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cowen and Company's CLBTW Position: Q2 2024 in Review

Cowen and Company sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q2 2024, closing a stake of 53,497 shares — an estimated $115K sold.

Cowen and Company first reported a position in CLBTW in Q3 2023 and held it in 3 quarters. The position peaked at $314K in Q4 2023. 19 funds tracked by Wall St. Rank hold CLBTW as of Q2 2024.

  • Cowen and Company reported no remaining Cellebrite DI Ltd. Warrants position as of Q2 2024 after selling out during the quarter.
  • Cowen and Company sold 53,497 Cellebrite DI Ltd. Warrants shares in Q2 2024, an estimated $115K.
  • Cowen and Company first reported a position in Cellebrite DI Ltd. Warrants in Q3 2023 and held it in 3 quarters.
  • Cowen and Company's Cellebrite DI Ltd. Warrants position peaked at $314K in Q4 2023.
  • 19 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q2 2024.

Based on Cowen and Company's 13F filing for Q2 2024, filed 7 Aug 2024.